Drug & intervention

doravirine

RxCUI 2055755

Clinical trials15
Recruiting3
Related conditions10
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

15 shown
Doravirine Dose Optimisation in PregnancyNCT05630638 · 2023-10-10
RECRUITING
Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy SwitchNCT04892654 · 2022-08-17
RECRUITING
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)NCT04375800 · 2021-02-03
RECRUITING
"Observational Study on Tolerability and Observance of Post-exposure Prophylaxis With Doravirine in HIV Viral Risk"NCT05761509 · 2023-06-08
COMPLETED
Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant WomenNCT04900974 · 2022-06-09
COMPLETED
HIV A6 Genome In ART Unsuccessful Patients On DORNCT05322083 · 2022-05-01
UNKNOWN
Non-Interventional Observational Retrospective Study to Evaluate Doravirine Based-regimens in HIV Infected Aged Patients (DORAge).NCT05202613 · 2022-01-04
UNKNOWN
Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)NCT04689737 · 2021-03-20
COMPLETED
HIV Switch Trial in Experienced Patients With Multiple Class Resistance Including NNRTI ResistanceNCT04334551 · 2020-06-23
UNKNOWN
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy VolunteersNCT03894124 · 2019-06-12
COMPLETED
Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)NCT03272347 · 2017-11-27
COMPLETED
Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)NCT02715700 · 2015-09-28
COMPLETED
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)NCT02275780 · 2014-12-01
COMPLETED
A Dose-Ranging Study to Compare Doravirine (MK-1439) Plus TRUVADA® Versus Efavirenz Plus TRUVADA® in Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-1439-007)NCT01632345 · 2012-10-12
COMPLETED
A Study of Doravirine (MK-1439) in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439-005)NCT01466985 · 2011-10-21
COMPLETED

Leading sponsors

Merck Sharp & Dohme LLC6Chelsea and Westminster NHS Foundation Trust2Clinique du Quartier Latin1Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia1Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation1Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba1University of Liverpool1University of North Carolina, Chapel Hill1University of Roma La Sapienza1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.